Q1 2023 Holdings
Filed 2023-05-12 | 120 holdings | $196.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $108.1M | 501,335 | 55.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $48.1M | 1,367,023 | 24.5% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $11.0M | 1,000,000 | 5.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $8.3M | 500,000 | 4.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $3.9M | 1,018,303 | 2.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $3.1M | 1,646,517 | 1.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $3.1M | 31,967 | 1.6% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.6M | 250,000 | 1.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $2.3M | 500,000 | 1.2% |
| Adagene Inc(ADAG) | ADS | 005329107 | $1.5M | 1,000,000 | 0.7% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $665.0K | 26,173 | 0.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $566.0K | 67,909 | 0.3% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $559.0K | 105,347 | 0.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $495.0K | 18,108 | 0.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $455.0K | 500,000 | 0.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $336.0K | 10,975 | 0.2% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $218.2K | 89,778,234 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $80.2K | 1,216,312 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $72.2K | 9,027,950 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $68.3K | 1,813,949 | 0.0% |
| WW Intl Inc(WW6) | COM | 98262P101 | $61.1K | 14,818,300 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $57.2K | 1,537,709 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $53.5K | 1,805,346 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $46.8K | 1,817,349 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $46.7K | 1,914,466 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $44.9K | 2,070,988 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $39.1K | 3,526,407 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $34.5K | 2,509,972 | 0.0% |
| Contrafect Corp(CFRXQ) | COM NEW | 212326409 | $34.0K | 18,750 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $33.0K | 412,082 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $31.5K | 750,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $27.6K | 1,673,743 | 0.0% |
| SEA LTD(SE) | SPONSORED ADS | 81141R100 | $26.2K | 302,500 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $23.8K | 15,631,235 | 0.0% |
| Allovir Inc | COM | 019818103 | $22.0K | 5,577,167 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $22.0K | 2,243,352 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $21.0K | 1,718,056 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $18.5K | 802,899 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $18.4K | 700,000 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $18.3K | 4,750,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $18.0K | 535,812 | 0.0% |
| Omega Therapeutics Inc | COM | 68217N105 | $15.3K | 2,533,045 | 0.0% |
| VOR Biopharma Inc | COM | 929033108 | $15.0K | 2,792,805 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $14.8K | 2,600,000 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $14.2K | 4,721,194 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $13.1K | 121,756 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $13.0K | 3,000,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $12.8K | 504,978 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $12.1K | 2,814,191 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $12.1K | 5,565,889 | 0.0% |